Loading clinical trials...
Loading clinical trials...
CITI-100 EA - Intermediate-Size Expanded Access, Open-Label Study for Use of Mino-Lok Therapy (MLT) in Combination With Systemic Antibiotics in the Treatment of Central Line Associated Bloodstream Infection
Conditions
Interventions
Mino-Lok Therapy (MLT)
Locations
30
United States
Phoenix VA Health Care System
Phoenix, Arizona, United States
Yale University School of Medicine
New Haven, Connecticut, United States
Georgetown University Hospital
Washington D.C., District of Columbia, United States
University of Florida - Shands Hospital - Dialysis Center
Gainesville, Florida, United States
Edward Hines Jr. VA Hospital
Hines, Illinois, United States
AMG Oncology
Park Ridge, Illinois, United States
Last Updated
August 14, 2020
NCT06905119
NCT04787926
NCT06095076
NCT06019897
NCT05651464
NCT03945045
Lead Sponsor
Leonard-Meron Biosciences, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions